
Loading, please wait...

Loading, please wait...

The Ministry of Health recently announced a significant leadership transition at the nation's premier medical institute. Dr Nikhil Tandon, the current Dean (Academic), will serve as the AIIMS Delhi Interim Director. This decision follows the departure of Dr M Srinivas, who moved to NITI Aayog as a full-time member. Consequently, the administration issued an official memorandum to ensure clinical and academic continuity during this period.
The appointment follows Rule 9(4) of the AIIMS Rules, 2019. Therefore, Dr Tandon will manage the director's functions alongside his existing responsibilities as Professor and Head of Endocrinology. This arrangement remains effective for six months or until a permanent director is selected. Furthermore, Dr Tandon will receive no additional remuneration for this specific interim role according to the memorandum.
Dr Tandon is a distinguished clinician-researcher specializing in cardio-metabolic diseases and diabetes. Because of his extensive experience, he has contributed to numerous national public health initiatives. He previously served on multiple expert groups focused on chronic disease management and obesity. Consequently, his leadership ensures that AIIMS maintains its high standards during this transition period.
This leadership shift comes as Dr M Srinivas joins NITI Aayog as a full-time member after serving as director since 2022. Although the change is temporary, it provides stability for the institute's operations. Meanwhile, the search for a regular incumbent continues under the guidance of the AIIMS President. This transition reflects the ongoing administrative evolution within India's top healthcare bodies.
Q1: Who has been appointed as the AIIMS Delhi Interim Director?
Dr Nikhil Tandon, the Dean (Academic) and Head of Endocrinology at the institute, has been assigned the duties of the director.
Q2: Why was a new interim director appointed?
The appointment follows the move of the previous director, Dr M Srinivas, to NITI Aayog as a full-time member.
Q3: How long will this interim arrangement last?
The arrangement is effective for six months or until a regular director is appointed, whichever occurs earlier.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Dr Nikhil Tandon, Dean (Academic), takes over as interim AIIMS Delhi Director following Dr M Srinivas's transition to NITI Aayog as a full-time member....
6 months ago

With India still adhering to 2009 air pollution benchmarks, the delayed NAAQS revision exposes populations to fine particulate matter far exceeding global safety limits. Clinicians face surging cardiopulmonary morbidity, emphasizing the urgent need for stringent, health-centered regulatory thresholds nationwide.
Today

India's leading assisted reproduction provider Indira IVF is in advanced talks to acquire a majority stake in Kerala's Sabine Hospital in a Rs 1,300 crore transaction. This strategic development highlights rising private equity interest, clinical consolidation, and changing demographic demands across reproductive medicine.
Today

Recent findings from the VESUVE study demonstrate that brain MRI detects intracranial lesions in over 76% of patients with infective endocarditis. Acute ischemic stroke and subarachnoid hemorrhage independently elevate six-month mortality, underscoring the critical prognostic utility of neuroimaging.
Yesterday

Modern 3D anthropometry reveals that pediatric leg growth ceases years before spinal elongation, exposing the clinical illusion of the classical Anderson-Green model. Learn how segmental growth dissociation improves surgical timing for epiphysiodesis in adolescent leg length discrepancy.
Yesterday

A meta-analysis of 18 studies reveals that bariatric surgery does not significantly alter circulating homocysteine levels, regardless of follow-up duration. Clinicians must maintain vigilance over post-surgical micronutrient supplementation to prevent hyperhomocysteinemia.
Yesterday